BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 1587398)

  • 21. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of metabolic markers to identify overweight individuals who are insulin resistant.
    McLaughlin T; Abbasi F; Cheal K; Chu J; Lamendola C; Reaven G
    Ann Intern Med; 2003 Nov; 139(10):802-9. PubMed ID: 14623617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustering of metabolic disorders and hyperinsulinemia in Mexico City.
    Zamora-González J; Yamamoto-Kimura L; Lerman-Garber I; Cardoso-Saldaña G; Fajardo-Gutierrez A; Posadas-Romero C
    Int J Obes Relat Metab Disord; 1996 Apr; 20(4):311-8. PubMed ID: 8680457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.
    Lindeman RD; Romero LJ; Hundley R; Allen AS; Liang HC; Baumgartner RN; Koehler KM; Schade DS; Garry PJ
    Diabetes Care; 1998 Jun; 21(6):959-66. PubMed ID: 9614614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective.
    Stern MP; Mitchell BD; Haffner SM; Hazuda HP
    Diabetes Care; 1992 May; 15(5):638-44. PubMed ID: 1516483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
    Haffner SM; Stern MP; Mitchell BD; Hazuda HP; Patterson JK
    Diabetes; 1990 Mar; 39(3):283-8. PubMed ID: 2407581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa Heart Study.
    Srinivasan SR; Frontini MG; Berenson GS;
    Metabolism; 2003 Apr; 52(4):443-50; discussion 451-3. PubMed ID: 12701056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic precursors of hypertension. The San Antonio Heart Study.
    Haffner SM; Miettinen H; Gaskill SP; Stern MP
    Arch Intern Med; 1996 Sep; 156(17):1994-2001. PubMed ID: 8823152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?
    Li C; Ford ES; Meng YX; Mokdad AH; Reaven GM
    Cardiovasc Diabetol; 2008 Feb; 7():4. PubMed ID: 18307789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico.
    Burke JP; Williams K; Haffner SM; Villalpando CG; Stern MP
    Diabetes Care; 2001 Sep; 24(9):1573-8. PubMed ID: 11522701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary heart disease risk factor profiles in black patients with non-insulin-dependent diabetes mellitus: paradoxic patterns.
    Banerji MA; Lebovitz HE
    Am J Med; 1991 Jul; 91(1):51-8. PubMed ID: 1858830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of two insulin assays in insulin resistance syndrome (syndrome X).
    Haffner SM; Mykkänen L; Valdez RA; Stern MP
    Arterioscler Thromb; 1994 Sep; 14(9):1430-7. PubMed ID: 8068604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.
    Haffner SM; Miettinen H; Stern MP
    Diabetes Care; 1996 Jan; 19(1):67-9. PubMed ID: 8720538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?
    Kim-Dorner SJ; Deuster PA; Zeno SA; Remaley AT; Poth M
    Metabolism; 2010 Feb; 59(2):299-304. PubMed ID: 19796777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass.
    Fischer S; Hanefeld M; Haffner SM; Fusch C; Schwanebeck U; Köhler C; Fücker K; Julius U
    Acta Diabetol; 2002 Sep; 39(3):105-10. PubMed ID: 12357293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
    Karter AJ; Mayer-Davis EJ; Selby JV; D'Agostino RB; Haffner SM; Sholinsky P; Bergman R; Saad MF; Hamman RF
    Diabetes; 1996 Nov; 45(11):1547-55. PubMed ID: 8866560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between surrogate measures of insulin resistance and waist circumference, cardiovascular risk and the metabolic syndrome across Hispanic and non-Hispanic white populations.
    Martínez-Larrad MT; Lorenzo C; González-Villalpando C; Gabriel R; Haffner SM; Serrano-Ríos M
    Diabet Med; 2012 Nov; 29(11):1390-4. PubMed ID: 22681498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites.
    Haffner SM; Stern MP; Hazuda HP; Rosenthal M; Knapp JA; Malina RM
    Diabetes Care; 1986; 9(2):153-61. PubMed ID: 3698781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado.
    Tudor SM; Hamman RF; Baron A; Johnson DW; Shetterly SM
    Diabetes Care; 1998 Jan; 21(1):53-61. PubMed ID: 9538971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.